| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/18/2005 | US6844327 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 01/18/2005 | US6844318 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 01/18/2005 | US6844181 Method of inhibiting fungal growth |
| 01/18/2005 | US6843992 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 01/18/2005 | CA2333686C Method and device for electrochemical immunoassay of multiple analytes |
| 01/18/2005 | CA2269638C Ice inhibiting peptides |
| 01/13/2005 | WO2005003292A2 Composition and method for self-assembly and mineralization of peptide amphiphiles |
| 01/13/2005 | WO2005002516A2 Leukocyte internalized peptide-drug conjugates |
| 01/13/2005 | WO2004026896A3 Hcv ns-3 serine protease inhibitors |
| 01/13/2005 | WO2003102592A3 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures |
| 01/13/2005 | US20050010060 Novel quinones as disease therapies |
| 01/13/2005 | US20050009747 High purity lipopeptides |
| 01/13/2005 | US20050009745 TSG101 as inhibitor of HIV production |
| 01/13/2005 | US20050009741 Copolymer made by depolymerizing chitosan and acylating such as with glutaryl and propionyl groups; mixture with peptides such as buserelin, deslorelin, histrelin; ionic conjugate with parathyroid hormone |
| 01/13/2005 | US20050009205 Fluorescently labeled G protein coupled receptor ligand comprising motilin for use in monitoring, identifying and screening drugs which modulate or treat cell proliferative disorders |
| 01/13/2005 | US20050009110 Identifying and rasing monoclonal antibodies specific to endothelial growth factors for use in the treatment and detection infection, autoimmune and cell proliferative disorders |
| 01/13/2005 | US20050009041 Peptide nucleic acids and synthetic procedures therefor |
| 01/13/2005 | US20050008653 In situ binding of polypeptide to stabilizer; induction apoptosis |
| 01/13/2005 | US20050008634 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 01/13/2005 | US20050008627 Administering tumor necrosis factor directly to lungs; asthma therapy; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050008603 Comb polymers; increase blood biocompatibility to inserts; reduce thrombogenicity ; oligosaccharide or oligopeptide side chain on polyvinyl amide, polyvinyl alcohol, polylysine |
| 01/13/2005 | CA2529555A1 Leukocyte internalized peptide-drug conjugates |
| 01/12/2005 | EP1495322A2 Heteroclitic analogs and related methods |
| 01/12/2005 | EP1495318A1 Method for detecting ligands and targets in a mixture |
| 01/12/2005 | EP1495054A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 01/12/2005 | EP1495052A1 Modified factor viii |
| 01/12/2005 | EP1495046A2 Selective melanin concentrating hormone type 1 receptor agonists |
| 01/12/2005 | EP1495045A1 Cytoplasmic transduction peptides and uses thereof |
| 01/12/2005 | EP1495006A1 Inhibitors of glycinamide ribonucleotide transformylase |
| 01/12/2005 | EP1494701A2 Immunosuppressant compounds, methods and uses related thereto |
| 01/12/2005 | EP1494695A1 Plasma protein-binding ligands |
| 01/12/2005 | EP0956029B1 Cyclic peptides having broad spectrum antimicrobial activity |
| 01/12/2005 | CN1563080A Analog of actinomycin D |
| 01/12/2005 | CN1563079A Adherence peptide specific to tissue of liver cancer obtained through sieve method in vitro, and usage |
| 01/12/2005 | CN1563078A Adherence peptide specific to tissue of liver cancer, screen method combined between in vivo and in vitro, and usage |
| 01/12/2005 | CN1563077A Adherence peptide specific to tissue of liver cancer obtained through sieve method in rivo, and usage |
| 01/12/2005 | CN1563076A Alpha-MSH analog for curing sexual disorder and preparation method |
| 01/12/2005 | CN1184235C Chimeric polypeptides, method for production and uses thereof |
| 01/11/2005 | US6841535 Peptide-mediated transfection agents and methods of use |
| 01/11/2005 | US6841385 Transcription factor E2F DNA-binding domain inhibitor peptides and their use |
| 01/06/2005 | WO2005000893A2 Pharmaceutical composition comprising cyclic somatostin analogues |
| 01/06/2005 | WO2005000879A1 Cyclosporin derivatives for the treatment of immune disorders |
| 01/06/2005 | WO2005000878A2 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 01/06/2005 | WO2005000876A2 Ring finger family proteins and uses related thereto |
| 01/06/2005 | WO2005000871A2 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 01/06/2005 | WO2005000870A2 Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof |
| 01/06/2005 | WO2005000351A2 Combination therapy for b cell disorders |
| 01/06/2005 | WO2005000192A2 Glycogen synthase kinase-3 inhibitors |
| 01/06/2005 | WO2004089960A3 Process for preparation of cyclosporin “a” analogues having a terminal diene group |
| 01/06/2005 | WO2004089396A3 Anti-fungal peptidomimetics |
| 01/06/2005 | WO2004074312A3 Tryptophyllin peptides and uses thereof |
| 01/06/2005 | US20050004040 Peptide having an affinity for gp120 |
| 01/06/2005 | US20050004036 Using angiotensin peptides; therapy for ulcer caused by allergens, human immunodeficiency virus, herpes virus infections; stresses; traumas |
| 01/06/2005 | US20050004035 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 01/06/2005 | US20050004019 Neuroprotective peptides and uses thereof |
| 01/06/2005 | US20050004014 New compound |
| 01/06/2005 | US20050004009 Peptidomimetic inhibitors of STAT activity and uses thereof |
| 01/06/2005 | US20050004000 Oral absorbed drugs |
| 01/06/2005 | US20050003466 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 01/06/2005 | US20050003425 Nucleotide sequences coding tumor marker protein for use in diagnosis and/or prognosis of cell proliferative disorders |
| 01/06/2005 | US20050003397 Peptide useful in immunomodulation |
| 01/06/2005 | US20050003358 Novel cancer marker and uses therefor in the diagnosis of cancer |
| 01/06/2005 | US20050003345 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 01/06/2005 | US20050002954 Peptide-based vaccine for influenza |
| 01/06/2005 | US20050002945 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 01/06/2005 | US20050002875 Peptide which binds to integrin |
| 01/06/2005 | CA2530111A1 Glycogen synthase kinase-3 inhibitors |
| 01/06/2005 | CA2530063A1 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 01/06/2005 | CA2528434A1 Combination therapy for b cell disorders |
| 01/06/2005 | CA2528343A1 Modulating the interaction between hgf beta chain and c-met |
| 01/05/2005 | EP1493748A1 Peptide chemically modified with polyethylene glycol |
| 01/05/2005 | EP1493030A2 Charge-balanced chemoselective linkers |
| 01/05/2005 | EP1492882A1 Methods and reagents for assaying protein kinase activity |
| 01/05/2005 | EP1492814A2 Novel peptides and the application thereof in therapy |
| 01/05/2005 | EP1326523A4 Imaging of enzymatic activity |
| 01/05/2005 | CN1560074A Polypeptide of inhibiting crown virus and its derivant |
| 01/05/2005 | CN1560073A Analogy short peptide at growth factor antigen surface position of basicity fibroblast and its sieving and using |
| 01/05/2005 | CN1183155C Peptide useful as ligand |
| 01/04/2005 | US6838553 Peptide repeat immunogens |
| 01/04/2005 | US6838475 For prophylaxis and therapy of one or more symptoms of hepatitis C |
| 01/04/2005 | US6838073 Cobalamin conjugates useful as imaging and therapeutic agents |
| 12/30/2004 | US20040266991 Biologically active peptides and their use for repairing injured nerves |
| 12/30/2004 | US20040266989 Methods and compositions for the treatment of gastrointestinal disorders |
| 12/30/2004 | US20040266731 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 12/30/2004 | US20040266696 activating neovascularization by administering heptapeptides having replacements in the amino acid sequence; antiischemic agents; regeneration and maintenance of artificial bones |
| 12/30/2004 | US20040266695 Novel LHRH antagonists having improved solubility properties |
| 12/30/2004 | US20040266694 Angiogenesis inhibitor induced by vascular endothelial growth factor |
| 12/30/2004 | US20040266692 Gastrointestinal disorders |
| 12/30/2004 | US20040266687 Antiproliferative agents; antiinflammatory agents; angiogenesis inhibitors; anticancer agents |
| 12/30/2004 | US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/30/2004 | US20040266675 Transgenic aniomal nmodels; screening; administering peptide |
| 12/30/2004 | US20040266673 Cardiovascular disorders; congestive heart failure |
| 12/30/2004 | US20040266671 Orally administered peptides synergize statin activity |
| 12/30/2004 | US20040266669 Cyclosporin derivatives for the treatment of immune disorders |
| 12/30/2004 | US20040266667 Streptogramin derivatives, preparation method and compositions containing same |
| 12/30/2004 | US20040266664 Enzyme inhibition |
| 12/30/2004 | US20040265982 Peptide or mimetic which enhances cholesterol ester hydrolase activity for use in identifying modulators for treatment and prevention of cardiovascular disorders |
| 12/30/2004 | US20040265974 Human chemokine polypeptides |
| 12/30/2004 | US20040265911 Peptides for use in culture media |
| 12/30/2004 | US20040265910 peptides which include cell-growth affecting peptides and peptides which enhance or inhibit production of cellular proteins formulated in culture medium to produce the desired effect on cultured cells; useful in concatemer-based recombinant expression methods |